Zynerba Pharmaceuticals Inc. (ZYNE) slipped -6.89% or -0.44 to $5.95. It is nearly 338868 shares traded, which is 96.26% compare to the average total volume 352036. The market cap of ZYNE is $104.86 million. The year to date change is -57.71%. The 52 week price range is from $5.03 to $15.13. Price of ZYNE have changed 8.12% during last week. It have changed -13.06% over last month, -2.74% over last 3 months, -29.00% over last 6 months and -41.38% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 7.07. It is 18.82% above current price. The 200-day Moving Averages for ZYNE is 8.95. It is 50.42% above current price. The 52-week High is 15.13. It is 154.29% from the current price. The 52-week Low is 5.03. It is -15.46% from current price.
There are some statistics of ZYNE. It is has market cap $104.86 million. The share outstanding is 17.62 million. The average volume is 352036. The percent of top 15 Institution holding is 16.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -72.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -61.23%.